These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9182546)

  • 1. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of protease-resistant prion protein in cell-free systems.
    Caughey B
    Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein and species barriers in the transmissible spongiform encephalopathies.
    Priola SA
    Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of transmissible spongiform encephalopathies.
    Weber T; Aguzzi A
    Intervirology; 1997; 40(2-3):198-212. PubMed ID: 9450236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
    Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
    EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation influences cross-species formation of protease-resistant prion protein.
    Priola SA; Lawson VA
    EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
    Horiuchi M; Priola SA; Chabry J; Caughey B
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.
    Lawson VA; Priola SA; Meade-White K; Lawson M; Chesebro B
    J Biol Chem; 2004 Apr; 279(14):13689-95. PubMed ID: 14736880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
    Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
    Lawson VA; Priola SA; Wehrly K; Chesebro B
    J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free formation of protease-resistant prion protein.
    Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
    Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting interactions between prion protein isoforms.
    Caughey B; Baron GS
    Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
    Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
    J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The most infectious prion protein particles.
    Silveira JR; Raymond GJ; Hughson AG; Race RE; Sim VL; Hayes SF; Caughey B
    Nature; 2005 Sep; 437(7056):257-61. PubMed ID: 16148934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.
    Caughey B; Raymond GJ; Priola SA; Kocisko DA; Race RE; Bessen RA; Lansbury PT; Chesebro B
    Mol Biotechnol; 1999 Nov; 13(1):45-55. PubMed ID: 10934521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP.
    Somerville RA
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1865-1872. PubMed ID: 10423157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
    Vorberg I; Raines A; Priola SA
    J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.